The FDA released a recent warning concerning lorcaserin, a weight-loss medication. 1 trial has found that this specific drug may increase the chance of cancer. If you take this medication or consider taking this drug, you’ll likely need to understand this information. It was only one trial conducted, so it is unknown if this does raise the risk of cancer. But, it’s still kind of concerning.
Lorcaserin, also known as Belviq, is a medication known for quite a long time. It was approved in 2012 to treat obesity or overweight people with at least one weight-related comorbidity. The manner Belviq works is it’s a selective serotonin 2C receptor agonist. It activates these receptors in the brain, and by doing so promotes sanity or the feeling of fullness, therefore decreasing food intake. Some common side effects that you could experience while taking Belviq include nausea, headache, and fatigue.
The FDA came out with a statement on January 14th concerning the lorcaserin. The statement said that the results from a clinical trial had shown that participants taking this medication did possibly have an elevated risk of cancer. It results from only one clinical trial; it did have few people in it but more needs to be done. Due to the limited results, the FDA couldn’t say what causes raised cancer risk. At this time, the cause of the cancer is uncertain, and we cannot conclude that lorcaserin contributes to the cancer threat.
Lorcaserin increased any risk of cardiovascular complications such as chest pain, heart attack, etc.; for those taking the medication, don’t freak up just yet. The FDA has not made any definite conclusion. There are billions of people in the world, so 1 trial of twelve thousand people is not enough. However, you do have to consider this information. With this new possibility of increased cancer risk, you want to ask yourself if the benefit of therapy still outweigh the risk. It is what the healthcare and you need to determine before continuing therapy with lorcaserin.
Lorcaserin drug on the market already shows some extraordinary results; it’s not just a fat diet because it’s FDA approved. The medication focuses less on the stomach and more on the brain. It’s the first weight-loss drug proven to have cardiovascular safety. Their composite scores are identical between patients who shot lorcaserin and patients in the placebo group. Overall there’s not a lot of use of pharmacologic weight loss agents in the usa. A whole lot of that is based on fear of the historic experience: they were not safe. So, now using a proven safe drug will lead more people to reach for a pharmacologic agent like lorcaserin.